Fotografi av Rosaura Casas

Rosaura Casas

Förste forskningsingenjör, Docent

Presentation

Publikationer

2023

Hugo Barcenilla, Mikael Pihl, Florence Sjögren, Louise Magnusson, Rosaura Casas (2023) Regulatory T-Cell Phenotyping Using CyTOF Regulatory T-Cells: Methods and Protocols, s. 231-242 (Kapitel i bok, del av antologi) Vidare till DOI
Sara Puente Marin, Fabricia Dietrich, Peter Achenbach, Hugo Barcenilla, Johnny Ludvigsson, Rosaura Casas (2023) Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype Frontiers in Immunology, Vol. 14, Artikel 1112570 (Artikel i tidskrift) Vidare till DOI
Ingrid K. Hals, Chandima Balasuriya, Rosaura Casas, Johnny Ludvigsson, Anneli Bjorklund, Valdemar Grill (2023) A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes Diabetes, obesity and metabolism, Vol. 25, s. 3400-3409 (Artikel i tidskrift) Vidare till DOI

2022

D Tatovic, M A McAteer, J Barry, A Barrientos, K Rodríguez Terradillos, I Perera, E Kochba, Y Levin, M Dul, S A Coulman, J C Birchall, C von Ruhland, A Howell, R Stenson, M Alhadj Ali, S D Luzio, G Dunseath, W Y Cheung, G Holland, K May, J R Ingram, M M U Chowdhury, F S Wong, Rosaura Casas, C Dayan, Johnny Ludvigsson (2022) Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes Immunotherapy Advances, Vol. 2, Artikel ltac002 (Artikel i tidskrift) Vidare till DOI
Johnny Ludvigsson, Linnea Eriksson, Christoph Nowak, Pedro F. Teixeira, Martina Widman, Anton Lindqvist, Rosaura Casas, Marcus Lind, Ulf Hannelius (2022) Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol BMJ Open, Vol. 12, Artikel e061776 (Artikel i tidskrift) Vidare till DOI

Forskning

Nyheter

Organisation